Cumba, Carmen G.
HRN: 17 34 49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2022
CEFTRIAXONE 1G (VIAL)
09/30/2022
10/07/2022
IV
2gm
OD
Urosepsis, CBC, UA
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes